A new synthesis of DL-5-vinyloxazolidine-2-thione, a natural antihyroid factor

DOI: 10.1002/jhet.5570270361

Source and publish data:

Journal of Heterocyclic Chemistry p. 811 - 812 (1990)

Update date:2022-08-17

Topics:

Authors:

Gardrat Gardrat

Latxague

Picard Picard

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jhet.5570270361

Full text of DOI:10.1002/jhet.5570270361

Products guided by the article

Product name:GOITRINE

Cas No:1072-93-1

R&D Labs maybe for 1072-93-1

A-Chem Technologies Co.,Ltd.

Contact:+86-512-69561895

Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Engineering Research Center of Pesticide, Heilongjiang Province

Contact:+86-451-86609001

Address:No.74 of Xuefu Road, Nangang District,
TIC Gums, Inc.

Contact:410-273-7300; 800-221-3953

Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
shanghai tuomiao chemicial co.,ltd.

website:https://www.tuomiaochem.com/

Contact:021 - 59853336

Address:shanghai
WENZHOU M&C FOREIGN TRADE CO.,LTD.

Contact:+86-577-88862917

Address:No.8 Liming West Road,Wenzhou,zhejiang,China

Relevant to this article

Formation of Acetylene in the Reaction of Methane with Iron Carbide Cluster Anions FeC₃^? under High-Temperature Conditions

Doi:10.1002/anie.201712463
(2018)
Solid phase applications of Dde and the analogue Nde: Synthesis of trypanothione disulphide

Doi:10.1016/S0040-4039(97)01010-1
(1997)
Heteropolytungstostannate as a homo- and heterogeneous catalyst for Knoevenagel condensations, selective oxidation of sulfides and oxidative amination of aldehydes

Doi:10.1039/c7ra06112a
(2017)
Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity

Doi:10.1016/j.bmcl.2010.03.118
(2010)
A 4-MeO-TEMPO, PEG-NO₂ and HCl catalytic system for highly efficient aerobic oxidation of alcohols

Doi:10.1055/s-0030-1258278
(2010)
Designer Cathinones N-Ethylhexedrone and Buphedrone Show Different In Vitro Neurotoxicity and Mice Behaviour Impairment

Doi:10.1007/s12640-020-00229-6
(2021)

Article Doi